plerixafor,busulfan
sanofi,pfizer,sangamo therapeutics,otsuka,crispr
['$sgmo', 'precizn-1', 'crispr', 'pfizer']
wf $sgmo @ #ash22 sickle cell precizn-1 patient #5 data #validate zfn gene editing #potency under new manufacturing process -hbf increased from 18.7% at baseline to 40.7% at w13 and 45.4% at w26
-total hb increased from 9.4 g/dl at baseline to 12.4 at w26 
Buy Side , private account , no advise , biotech